Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Vincent

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Neurology|November 15, 2023
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experienceAndrew Blumenfeld, Stewart J Tepper, Rashna Khanna, et al.
Neuroreport|April 17, 2007
Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraineAlexandre F M DaSilva, Cristina Granziera, David S Tuch, et al.
Cephalalgia : an International Journal of Headache|August 18, 2022
Efficacy of lasmiditan for the acute treatment of perimenstrual migraineE Anne MacGregor, Mika Komori, John Henry Krege, et al.
Pain and Therapy|April 28, 2026
Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive MedicationsCristina Tassorelli, Diego Novick, Saygin Gonderten, et al.
The Journal of Headache and Pain|March 26, 2014
Cuneus and fusiform cortices thickness is reduced in trigeminal neuralgiaMaud Parise, Tadeu Takao Almodovar Kubo, Thomas Martin Doring, et al.
Pain and Therapy|April 26, 2022
Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc AnalysisJohn H Krege, Richard B Lipton, Simin K Baygani, et al.
Current Medical Research and Opinion|March 31, 2021
Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe painMario F P Peres, Raghavendra Vasudeva, Simin K Baygani, et al.
Pain and Therapy|April 25, 2020
Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence StudyHu Li, Maurice Vincent, Xiang Zhang, et al.
Headache|April 22, 2026
Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH studyShivang Joshi, Cristina Tassorelli, Manjit Matharu, et al.
Headache|September 29, 2025
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH studyRichard B Lipton, Miguel J A Láinez, Zubair Ahmed, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Neurology|November 15, 2023
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experienceAndrew Blumenfeld, Stewart J Tepper, Rashna Khanna, et al.
Neuroreport|April 17, 2007
Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraineAlexandre F M DaSilva, Cristina Granziera, David S Tuch, et al.
Cephalalgia : an International Journal of Headache|August 18, 2022
Efficacy of lasmiditan for the acute treatment of perimenstrual migraineE Anne MacGregor, Mika Komori, John Henry Krege, et al.
Pain and Therapy|April 28, 2026
Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive MedicationsCristina Tassorelli, Diego Novick, Saygin Gonderten, et al.
The Journal of Headache and Pain|March 26, 2014
Cuneus and fusiform cortices thickness is reduced in trigeminal neuralgiaMaud Parise, Tadeu Takao Almodovar Kubo, Thomas Martin Doring, et al.
Pain and Therapy|April 26, 2022
Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc AnalysisJohn H Krege, Richard B Lipton, Simin K Baygani, et al.
Current Medical Research and Opinion|March 31, 2021
Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe painMario F P Peres, Raghavendra Vasudeva, Simin K Baygani, et al.
Pain and Therapy|April 25, 2020
Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence StudyHu Li, Maurice Vincent, Xiang Zhang, et al.
Headache|April 22, 2026
Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH studyShivang Joshi, Cristina Tassorelli, Manjit Matharu, et al.
Headache|September 29, 2025
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH studyRichard B Lipton, Miguel J A Láinez, Zubair Ahmed, et al.
Pageof 4